Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, et al
Report any suspected side effects via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk) or to your prescriber
If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
The 14 mg oral dose provides roughly equivalent effects to 0.5 mg to 1 mg injectable semaglutide, meaning it may not match the effect of moderate to high tirzepatide doses
This step helps calculate accurate final concentrations
Protein sequence analysis using the MPI bioinformatics toolkit
